Servizi
Asabys Partners Integrates Aliath Bioventures Life Sciences Investment Platform in Strategic Move with AltamarCAM
The investment teams from both firms have collaborated for many years and co-invested in Deepull, Ona Therapeutics, and Inbrain Neuroelectronics. United by a shared vision and complementary approach, this combination strengthens capabilities and creates synergies amid a consolidating, complex market. Companies in the Alta Life Sciences Spain I FCR fund continue to perform well and will be supported by Asabys going forward. Future plans include the launch of a new fund in early 2026, alongside other strategic healthcare funds, to accelerate expansion and build its leadership to become one of the largest life-science GPs in Southern Europe .
,
As part of the agreement, the Alta Life Sciences Spain I FCR fund will be co-managed by both Asabys and AltamarCAM. Asabys' founding partners, Clara Campàs and Josep Sanfeliu , will join the Fund's Investment Committee. The Aliath Bioventures team will be fully integrated into Asabys, with Montserrat Vendrell and José María Fernández becoming partners at the firm.
, "
Asabys Partners is a venture capital firm specialized in the healthcare sector, founded in 2018 by Josep Ll. Sanfeliu and Clara Campàs, with Alantra as a shareholder and Banc Sabadell as anchor investor. With close to €300 million in AUM and 18 portfolio companies (+2 divestments), Asabys invests in highly innovative and disruptive companies addressing unmet medical needs in the biopharmaceutical and healthtech verticals.
AltamarCAM Partners is a global investment firm focused on private markets, with the primary objective of providing institutional investors —including insurance companies, pension funds, and financial institutions— as well as high-net-worth individuals, with efficient access to investment in unlisted markets: private equity, venture capital, life sciences, real assets (real estate and infrastructure), and private debt/credit. The firm does so through a selection of international managers and by accessing them via various strategies (primary, secondary, co-investments, and direct investments).
With offices in Madrid , Cologne , Barcelona , New York , London , Santiago de Chile , and Munich , AltamarCAM Partners has a team of around 300 people and more than €20 billion in committed capital from investors.
View original content:https://www.prnewswire.co.uk/news-releases/asabys-partners-integrates-aliath-bioventures-life-sciences-investment-platform-in-strategic-move-with-altamarcam-302573097.html